TuisIMRSQ • OTCMKTS
add
IMRIS Ord Shs
Vorige sluiting
$0,00
Gemiddelde volume
372,00
P/V-verhouding
-
Dividend-opbrengs
-
Marknuus
Finansieel
Inkomstestaat
Inkomste
Netto inkomste
| (USD) | 2014info | J/J-verandering |
|---|---|---|
Inkomste | 28,89 m | — |
Bedryfskoste | 33,07 m | — |
Netto inkomste | -30,39 m | — |
Netto winsgrens | -105,18 | — |
Wins per aandeel | -0,58 | 30,12% |
EBITDA | -20,30 m | — |
Effektiewe belastingkoers | -0,80% | — |
Balansstaat
Totale bates
Totale aanspreeklikheid
| (USD) | 2014info | J/J-verandering |
|---|---|---|
Kontant en korttermynbeleggings | 5,00 m | — |
Totale bates | 65,48 m | — |
Totale aanspreeklikheid | 53,69 m | — |
Totale ekwiteit | 11,79 m | — |
Uitstaande aandele | 62,59 m | — |
Prys om te bespreek | 0,00 | — |
Opbrengs op bates | -19,15% | — |
Opbrengs op kapitaal | -31,61% | — |
Kontantvloei
Netto kontantverandering
| (USD) | 2014info | J/J-verandering |
|---|---|---|
Netto inkomste | -30,39 m | — |
Kontant van bedrywe | -10,91 m | — |
Kontant van beleggings | 4,49 m | — |
Kontant van finansiering | 3,50 m | — |
Netto kontantverandering | -1,38 m | — |
Beskikbare kontantvloei | 4,58 m | — |
Meer oor
IMRIS, founded in 2005, is a global provider of intraoperative imaging solutions.
The company's flagship product is the IMRIS Surgical Theatre. A hybrid operating theatre with intraoperative imaging capabilities, The IMRIS Surgical Theatre incorporates design and technology provided by IMRIS, including the moveable intraoperative MRI, as well as technology from 3rd-party medical device companies. IMRIS designs, creates and supports the IMRIS Surgical Theatre, which the company's marketing materials describe as "the world's most advanced hybrid operating theatre." Wikipedia
Gestig
2005
Hoofkwartier
Webwerf
Werknemers
121
